Sign Up to like & get
recommendations!
1
Published in 2020 at "Value in Health"
DOI: 10.1016/j.jval.2020.08.1458
Abstract: Objectives: To explore the impact of Covid-19 on the pricing, market access, and payer evidence requirements in disease areas where new therapies or diagnostics are expected to be “payer disruptive” Methods: A survey-based Covid-19 payer…
read more here.
Keywords:
disruptive innovation;
impact;
disease areas;
turbulence disruptive ... See more keywords